IO Biotech
IOBT
IOBT
18 hedge funds and large institutions have $72.2M invested in IO Biotech in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.72M | |
| 2 | +$350K | |
| 3 | +$67K | |
| 4 |
Morgan Stanley
New York
|
+$35.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10K |
Top Sellers
| 1 | -$523K | |
| 2 | -$330K | |
| 3 | -$141K | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$133K |
| 5 |
Millennium Management
New York
|
-$124K |